AddToAny buttons

Article and Video CATEGORIES

Cancer Journey

Search By

ABOUT
Denise Brock

Denise has over 30 years of varying experience in the healthcare arena.  In August 2009 she joined The Global Resource for Advancing Cancer Education as one of its first employees.  She has grown with the organization and now oversees the operational movement of programs, efficiency, and effectiveness within the organization, as well as the daily processes and functions.  

 

Board News! Nancy Sladicka Appointed Next GRACE Board President
Introducing Nancy Sladicka, PhD, GRACE Board President!
Author
Denise Brock

The board and staff at the Global Resource for Advancing Cancer Education (GRACE) are very pleased to announce the appointment of Nancy Iler Sladicka, Ph.D. as President of the Board of Directors effective November 3, 2023.  


 

In this role, Nancy will guide the strategic priorities of the organization and preside over the Board meetings, working closely with Amy Bickleman, Executive Director, and Matt Tan, Vice President.

Image
Nancy Sladicka 11.2023

 

 

Nancy brings over 25 years of experience in healthcare communications (including CME, publication planning, Medical Affairs support, clinical trial awareness initiatives, patient education, and peer-to-peer programming), with much of her career supporting clinical development and medical education efforts related to new cancer therapies. Nancy is currently Chief Strategy Officer at Nucleus Global, an Inizio company, and was previously President, US Operations where she was responsible for the overall business operations and financial health of the region for a period of 5 years.

 

Nancy has been a long-standing member of the GRACE Board of Directors since 2009 and will be assuming the President role from and finishing the term previously held by, Howard (Jack) West, MD, who is stepping down given his recent move from City of Hope to Summit Therapeutics. Dr. West is the Founder of GRACE and will remain deeply involved on the Board of Directors as Past President.

 

On expanding her Board role, Nancy commented "I'm honored to serve in this new capacity and firmly believe in the mission of this organization. I look forward to continuing to work with Jack and this incredible Board of Directors; and plan to leverage my relationships and knowledge of the pharma industry to continue the great work of GRACE in providing credible, expert-mediated information to improve the overall care of cancer patients.”

 

We have worked closely with Nancy for many years and know her as a dedicated, warm, wonderful part of the GRACE family.  We are thrilled by her acceptance of this new role and continue to work to uphold the mission of GRACE.  

 

"The Global Resource for Advancing Cancer Education (GRACE) provides expert-mediated information on current and emerging cancer management options in order to empower patients, caregivers, and health professionals to become direct partners in cancer care."

 

For Nancy's full bio - please scroll down on our staff and board page.

 

Please join us in welcoming Nancy as the GRACE Board President! 

 


 

Next Previous link

Previous PostNext Post

Related Content

Image
Blood Cancers OncTalk
Article
Registration is now open! Join us for the annual 2024 Blood Cancers OncTalk!  Register Now!
Image
PEA 2024-25 final
Article
GRACE is pleased to announce the acceptance of five rising stars into the 6th year of the GRACE Patient Education Ambassadors Program for the 2024-25 Program Year! 
Image
2024 patient education ambassadors program
Article
Applications are now open to oncology fellows and finishing fellows Program Information Form and Application

Forum Discussions

Hi elysianfields and welcome to Grace.  I'm sorry to hear about your father's progression. 

 

Unfortunately, lepto remains a difficult area to treat.  Recently FDA approved the combo Lazertinib and Amivantamab...

Hello Janine, thank you for your reply.

Do you happen to know whether it's common practice or if it's worth taking lazertinib without amivantamab? From all the articles I've come across...

Hi elysianfields,

 

That's not a question we can answer. It depends on the individual's health. I've linked the study comparing intravenous vs. IV infusions of the doublet lazertinib and amivantamab...

Recent Comments

JOIN THE CONVERSATION
That's just beautiful Linda…
By JanineT GRACE … on
I could not find any info on…
By JanineT GRACE … on
Hi elysianfields,

 

That's…
By JanineT GRACE … on
Hello Janine, thank you for…
By elysianfields on